2017 Agenda

Download the agenda as a PDF

Wed, 07/12

8:00 AM – 9:00 AM
Breakfast Roundtable Discussions Kick off Partnering for Cures with an opportunity to network with peers who share your goals and interests. These roundtables bring together meeting participants across disciplines and sectors to discuss specific topics in biomedical R&D. Table topics and hosts are listed below. Biosimilars: Changing the Value Equation
8:00 AM – 5:00 PM
Partnering Web-based partnering app, P4C Connect, allows participants to connect with nontraditional allies who can help advance their research and development goals. Partnering happens throughout the meeting, in addition to designated partnering breaks in between program elements.
9:00 AM – 9:15 AM
Introductory Remarks

9:15 AM – 9:45 AM
P4C Unplugged with Robert Langer
Robert Langer is the ultimate multi-hyphenate, an engineer-scientist-entrepreneur-inventor who leads one of the largest and most prolific biomedical research labs in the world making a dizzying array of scientific discoveries. Through the decades, he has seen and been a part of incredible breakthroughs in biomaterials, regenerative medicine and nanotechnology.


  • Robert Langer
    David H. Koch Institute Professor, Massachusetts Institute of Technology
9:45 AM – 10:45 AM
Patient-centricity: What's the Return on Engagement?
As Partnering for Cures kicked off in Boston, Kim McCleary, managing director of FasterCures, began the opening plenary by drawing a parallel between the host city as a site of the "revolutionary thinking" by the American colonists and the revolution that's occurring in the way diseases are researched and...


  • Michael Goettler
    Global President, Rare Disease, Pfizer
  • Theresa Mullin
    Director, Office of Strategic Programs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
  • Joe Selby
    Executive Director, Patient-Centered Outcomes Research Institute
  • Tania Simoncelli
    Executive Director, Count Me In, Broad Institute of MIT and Harvard
  • Laura Sol
    Chief of Staff to the CEO, American Heart Association
11:15 AM – 12:15 PM
Reimagining the Future of Science with a New Generation of Investigators
A record-high 80 percent of biomedical researchers with a Ph.D. are now working outside academia. Millennials are currently the largest living generation and bring new priorities, expectations, and skills to health and research. Yet even after decades of national blue-ribbon commissions and reports on the need to provide more...


  • Kafui Dzirasa
    Assistant Professor, Departments of Neurobiology, Biomedical Engineering, and Psychiatry and Behavioral Sciences, Duke University Medical Center
  • Kristin Krukenberg
    Senior Scientist, Shire; Founder and Board Member, Future of Research
  • Daisy Robinton
    Postdoctoral Scientist, Harvard University and ‎Boston Children's Hospital
  • David Van Vactor
    Professor, Cell Biology, Harvard Medical School
Workshop: Sharing "Scruffy" Data
We know that bad data produces unusable results, but gone are the days of using only pristine clinical trials data to draw conclusions and make decisions. 'Scruffy' data can come in many forms: real-world data, data from wearable devices, and other non-clinical trial data sets.

  • John Wilbanks
    Chief Commons Officer, Sage Bionetworks; Senior Fellow, FasterCures

  • Patricia Brennan
    Director, National Library of Medicine; Interim Associate Director for Data Science, National Institutes of Health
  • Len D'Avolio
    CEO and Co-Founder, Cyft; Assistant Professor, Harvard Medical School
  • Harlan Krumholz
    Harold H. Hines, Jr. Professor of Medicine, Yale School of Medicine; Director, Center for Outcomes Research and Evaluation, Yale New Haven Hospital
  • Heidi Rehm
    Associate Professor of Pathology, Brigham and Women's Hospital and Harvard Medical School; Director, Partners Laboratory for Molecular Medicine
12:30 PM – 1:00 PM

1:00 PM – 2:00 PM
Partnering for Productivity: What's Working to Populate the Pipeline?
Matthew Herper of Forbes Magazine observed that "getting to faster cures is a team sport." As the moderator of the lunch plenary at Partnering for Cures in Boston, he acknowledged that this statement would come as no surprise to folks in the room.


2:30 PM – 3:30 PM
Getting What You Measure: Incentives for Collaboration
Incentives for academic and industry scientists are not always aligned with the kinds of behaviors we all say we want to see more of in science – more open sharing of data and knowledge, more team science and transdisciplinary work to solve challenging problems, more cross-sector collaboration to speed...


  • Robi Blumenstein
    President, CHDI Foundation
  • Carolyn Buser
    Senior Fellow, Vice President, and Global Head of Discovery Partnerships with Academia, GSK
  • Gigi Hirsch
    Executive Director, MIT Center for Biomedical Innovation
  • Daniel Wattendorf
    Director, Innovative Technology Solutions, Bill & Melinda Gates Foundation
  • Carrie Wolinetz
    Acting Chief of Staff and Associate Director for Science Policy, National Institutes of Health
Workshop: Conquering Clinical Research: Engagement Today for Cures Tomorrow
Expediting recruitment for clinical trials has long been talked about as a magic bullet for speeding up medical research, saving time and money, and partnering with patients. Today's technological advances and tools are transforming the ways patients connect with researchers, foundations, companies, and each other.

  • Jason Bobe
    Associate Professor and Director, Sharing Lab, Icahn Institute for Genomics and Multiscale Biology, Mount Sinai School of Medicine

  • Kristin Carman
    Director of Public and Patient Engagement, Patient-Centered Outcomes Research Institute
  • Sohini Chowdhury
    Deputy CEO, The Michael J. Fox Foundation for Parkinson's Research
  • Holly Fernandez Lynch
    Executive Director, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard Law School; Faculty, Center for Bioethics, Harvard Medical School
  • Anna McCollister-Slipp
    Founder, VitalCrowd; Chief Advocate, Participatory Research, Scripps Translational Science Institute
  • Rachel Wagman
    Executive Director, Global Clinical Development, Amgen
3:45 PM – 4:00 PM
Time=Lives Talk: Research, Collaboration, and Remission
David Fajgenbaum entered medical school on a quest to cure cancer, the disease that claimed his mother's life. He didn't know that his medical training would ultimately serve a mission to cure himself. At 25, Fajgenbaum was diagnosed with idiopathic multicentric Castleman disease (iMCD), a disease that has brought...

  • David Fajgenbaum
    Associate Director, Patient Impact, Orphan Disease Center, University of Pennsylvania; Co-Founder & Executive Director, Castleman Disease Collaborative Network
4:00 PM – 5:00 PM
Day 173: The Federal Policy Landscape, and Why It Matters to You
On the 173rd day of the Trump administration, Partnering for Cures Boston closed with a discussion, moderated by CNBC Reporter Meg Tirrell, on the federal policy landscape, including panelists' perspectives on the current system and the future of federal policy.


  • Mark Alles
    CEO, Celgene
  • Marc Boutin
    CEO, National Health Council
  • Robert Califf
    Vice Chancellor for Health Data Science and Director of the Center for Integrated Health Data Science, Duke Health; Donald F. Fortin, MD Professor of Cardiology, Duke University School of Medicine
  • Cynthia Rice
    Senior Vice President, Advocacy & Policy, JDRF
5:00 PM – 6:00 PM